Company / Revenue per Share
InMed Pharmaceuticals Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$10.31
FY2025
5-year range
$1.24 / $10.31
FY2022-FY2025
Trend
+729.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +730% YoY in FY2025, a notable deviation from the 3-year average annual change of +218%.
Based on SEC 10-K filings.
10.31 in FY2025 with a 3-year CAGR of +45.0%.
Improved from $1.67 to $10.31 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +45.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 729.8% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.31 | +729.8% |
| FY2024 | $1.24 | -25.8% |
| FY2023 | $1.67 | -50.5% |
| FY2022 | $3.38 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026